SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genta, Inc. (GNTA)
GNTA 2.300+0.4%Nov 7 3:57 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scotty who wrote (1648)9/25/2002 2:56:02 PM
From: scotty  Read Replies (1) of 1870
 
cool post from message board by rai_gl_208..... "NCI wouldn't continue to target new cancer types for children if they weren't based on some very promising results.I have some knowledge of how the NCI operates, and I can tell you that they wouldn't contemplate using their precious funds if Genasense didn't demonstrate safety and efficacy. The NCI's board consider many promising candidate trials to fund, but they have limited funds.To sponsor trial after trial with Genasense for children is unheard of, yes unheard of! In some ways I am surprised that the FDA doesn't provide conditional use now. With a new director they just might. European approval is a possibility well before FDA. These announcements are huge. I believe you are seeing the reality of these recent announcements in the beginnings of short covering. This stock is literally worth hundreds maybe more."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext